Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal SARS-CoV2 orf8 antibody. Carrier free. Suitable for ELISA, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with SARS-CoV-2, Transfected cell line - SARS-CoV-2 samples.
View Alternative Names
ORF8 protein, ORF8, Non-structural protein 8, ns8, 8
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (AB284042)
Intracellular Flow Cytometry analysis of HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cells transfected with a SARS-COV2 orf7a expression vector containing a GFP tag labeling SARS-CoV2 orf8 with ab283914 at 1/500 dilution (right). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti-rabbit IgG (Alexa Fluor® 647, ab150083) secondary antibody was used at 1/5000 dilution. Isotype control - Rabbit monoclonal IgG (left) (ab172730). No cross-reactivity with SARS-COV2 orf7a.
This data was developed using ab283914, the same antibody clone in a different buffer formulation.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (AB284042)
Intracellular Flow Cytometry analysis of HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cells transfected with a SARS-CoV2 orf8 expression vector containing a myc tag labeling SARS-CoV2 orf8 with ab283914 at 1/500 dilution (right). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti-rabbit IgG (Alexa Fluor® 488, ab150081) secondary antibody was used at 1/5000 dilution. Isotype control - Rabbit monoclonal IgG (left) (ab172730).
This data was developed using ab283914, the same antibody clone in a different buffer formulation.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (AB284042)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cells labelling SARS-CoV2 orf8 with primary antibody anti-SARS-CoV2 orf8 (ab283914) at 1/100 dilution, followed by AlexaFluor®594 Goat anti-Rabbit (green) (ab150088) secondary antibody at 1/1000 dilution. Confocal image showing cytoplasmic and nuclear staining in HEK-293T cells transfected with a SARS-CoV2 orf8 expression vector containing a myc tag, no staining in HEK-293T cells transfected with a SARS-COV2 orf7a expression vector containing a myc tag. Myc-Tag Mouse mab (Alexa Fluor® 647) (red) was used to counterstain at 1/100 dilution. The nuclear counter stain is DAPI (blue).
This data was developed using ab283914, the same antibody clone in a different buffer formulation.
- IHC-P
AbReview84149****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (AB284042)
This data was developed using ab283914, the same antibody clone in a different buffer formulation. ab283914 staining SARS-CoV-2 nsp8 in Human Lung (SARS-CoV-2 RNA+) tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde, antigen retrieval was by heat mediation in a EDTA Buffer (pH 9). Samples were incubated with primary antibody (1/100) for 45 minutes at 24°C. A Rabbit HRP-conjugated secondary antibody was used.
This image is courtesy of an Abreview submitted by Dr, Aron Emmi
- ELISA
Lab
ELISA - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (AB284042)
This data was developed using ab283914, the same antibody clone in a different buffer formulation.
Indirect ELISA showing primary antibody ab283914 binding to SARS-CoV2 ORF8 (AA 16-121) protein (His tag). Plates were coated with SARS-CoV2 ORF8 (AA 16-121) protein (His tag) and Recombinant SARS-CoV2 ORF7a Fc Chimera protein at 1000 ng/ml. Binding of ab283914 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution).
Binding was detected using pre-adsorbed secondary antibody, goat anti-rabbit IgG H&L (HRP, ab97080) at 1/2000 dilution.
- WB
Lab
Western blot - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (AB284042)
This data was developed using ab283914, the same antibody clone in a different buffer formulation.
Lanes 1 & 2 : Red – loading control ab18184 (Mouse monoclonal [HIS.H8] to 6X His tag®) observed at 27 kDa.
Lanes 3 & 4 : Green – ab283914 observed at 27 kDa.
ab283914 was shown to bind specifically to SARS-CoV-2 ORF8 protein in Western blot. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab18184) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution
Blocking buffer : 3% milk in TBS-0.1 % Tween® 20 (TBS-T).
Lanes 1 - 2:
Western blot - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (ab284042)
Lanes 3 - 4:
Western blot - Anti-SARS-CoV2 orf8 antibody [EPR24851-65] - BSA and Azide free (ab284042) at 1/20000 dilution
Lanes 1 and 3:
SARS-CoV-2 ORF8 (AA 16-121) protein (His tagged) at 0.5 µg
Lanes 2 and 4:
SARS-CoV-2 ORF8 (AA 16-121) protein (His tagged) at 0.2 µg
false
Related conjugates and formulations (1)
-
Anti-SARS-CoV2 orf8 antibody [EPR24851-65]
Reactivity data
Product details
ab284042 is the carrier-free version of ab283914
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The Orf8 protein interacts with host cellular machinery to affect immune response. It is not part of any known stable complexes but it modulates the unfolded protein response (UPR) in cells influencing how proteins fold and maintaining cellular homeostasis under stress conditions. Orf8 can also impact the major histocompatibility complex class I (MHC-I) pathway which has implications on immune evasion by the virus.
Pathways
Studies indicate that SARS-CoV-2 Orf8 plays roles in immune modulation and protein processing pathways. It interacts with the UPR pathway notably affecting the IRE1 signaling. Comparisons to other viral accessory proteins such as SARS-CoV-2 Orf3b reveal distinct impacts on host immune responses illustrating the diverse strategies the virus employs to enhance survival and replication.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com